Jones Financial Companies
KRYS icon

Jones Financial Companies’s Krystal Biotech KRYS Stock Holding History

Jones Financial Companies’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162K Buy
655
+365
+126% +$97.1K ﹤0.01% 2469
2025
Q4 		$71.5K Buy
290
+253
+684% +$53.3K ﹤0.01% 2368
2025
Q3 		$6.21K Buy
37
+5
+16% +$748 ﹤0.01% 3280
2025
Q2 		$4.44K Buy
+32
New +$4.7K ﹤0.01% 3173

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jones Financial Companies's KRYS Position: Q1 2026 in Review

Jones Financial Companies increased its Krystal Biotech (KRYS) stake by 126% in Q1 2026, buying an estimated $97.1K and bringing the position to 655 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.

Jones Financial Companies first reported a position in KRYS in Q2 2025 and has held it in 4 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Jones Financial Companies held 655 shares of Krystal Biotech worth $162K as of Q1 2026.
  • Jones Financial Companies bought 365 Krystal Biotech shares in Q1 2026, an estimated $97.1K.
  • Krystal Biotech made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #2469 holding.
  • Jones Financial Companies first reported a position in Krystal Biotech in Q2 2025 and has held it in 4 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.